These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1703118)

  • 1. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fate of polycythemia vera treated by radioactive phosphorus. Apropos of a series of 303 patients followed for 12 to 24 years].
    Tubiana M; Attie E; Parmentier C
    Nouv Presse Med; 1975 Jun; 4(24):1781-6. PubMed ID: 1161478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
    Krańik W
    Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course and transformation of polycythaemia vera in relation to therapy.
    Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
    Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
    Sánchez Fayos J; Prieto E; Román A; Soto de Ozaeta C; Nevado I; Richart A; Chica E; Loscertales J; Calabuig T; Benítez J; Outeiriño J
    Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycythaemia vera--diagnosis and therapy].
    Lechner K; Geissler K; Gisslinger H
    Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of 259 patients with primary proliferative polycythaemia (PPP) and idiopathic thrombocythaemia (IT) treated in a regional nuclear medicine department with phosphorus-32--a 15 year review.
    Balan KK; Critchley M
    Br J Radiol; 1997 Nov; 70(839):1169-73. PubMed ID: 9536909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiophosphorus therapy of polycythemia vera].
    Hör G; Pabst HW
    Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
    Tesselaar ME; Wijermans PW; Metsaars JA; Gerrits WB; Haak HL
    Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1900-2. PubMed ID: 8927166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up of a patient with accidental phosphor 32 overdose].
    Holy D; Caduff B; Kistler HJ
    Schweiz Med Wochenschr; 1994 Oct; 124(42):1848-51. PubMed ID: 7973511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
    Randi ML; Fabris F; Visentin I; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
    Rain JD
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of polycythemia. I--Using radiophosphorus with or without treatment in 483 patients over 65 years of age].
    Najean Y; Rain JD; Goguel A; Grange MJ; Vigneron N; Dupuy E; Mougeot-Martin M
    Ann Med Interne (Paris); 1998 Mar; 149(2):87-93. PubMed ID: 11490530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT; Peterson P; Geller SA; Rappaport H
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-relationship between polycythaemia vera, leukaemia and myeloid metaplasia.
    Modan B
    Clin Haematol; 1975 Jun; 4(2):427-39. PubMed ID: 1102196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.